Inogen (INGN) Competitors $6.67 -0.08 (-1.24%) As of 10:19 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INGN vs. BBNX, CBLL, DCTH, AVNS, BFLY, BVS, KIDS, NPCE, AXGN, and SMLRShould you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Beta Bionics (BBNX), CeriBell (CBLL), Delcath Systems (DCTH), Avanos Medical (AVNS), Butterfly Network (BFLY), Bioventus (BVS), OrthoPediatrics (KIDS), NeuroPace (NPCE), AxoGen (AXGN), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Inogen vs. Beta Bionics CeriBell Delcath Systems Avanos Medical Butterfly Network Bioventus OrthoPediatrics NeuroPace AxoGen Semler Scientific Beta Bionics (NASDAQ:BBNX) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends. Which has preferable valuation & earnings, BBNX or INGN? Beta Bionics has higher earnings, but lower revenue than Inogen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$69.83M9.43N/AN/AN/AInogen$339.96M0.53-$102.45M-$1.15-5.80 Do insiders & institutionals believe in BBNX or INGN? 89.9% of Inogen shares are owned by institutional investors. 1.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor BBNX or INGN? Inogen received 384 more outperform votes than Beta Bionics when rated by MarketBeat users. Likewise, 68.78% of users gave Inogen an outperform vote while only 66.67% of users gave Beta Bionics an outperform vote. CompanyUnderperformOutperformBeta BionicsOutperform Votes666.67% Underperform Votes333.33% InogenOutperform Votes39068.78% Underperform Votes17731.22% Does the media refer more to BBNX or INGN? In the previous week, Inogen had 5 more articles in the media than Beta Bionics. MarketBeat recorded 5 mentions for Inogen and 0 mentions for Beta Bionics. Inogen's average media sentiment score of 0.96 beat Beta Bionics' score of 0.00 indicating that Inogen is being referred to more favorably in the news media. Company Overall Sentiment Beta Bionics Neutral Inogen Positive Do analysts prefer BBNX or INGN? Beta Bionics currently has a consensus target price of $24.83, indicating a potential upside of 63.48%. Inogen has a consensus target price of $9.50, indicating a potential upside of 42.51%. Given Beta Bionics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Beta Bionics is more favorable than Inogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78Inogen 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is BBNX or INGN more profitable? Beta Bionics has a net margin of 0.00% compared to Inogen's net margin of -15.89%. Beta Bionics' return on equity of 0.00% beat Inogen's return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Inogen -15.89%-27.38%-16.77% SummaryBeta Bionics beats Inogen on 8 of the 15 factors compared between the two stocks. Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INGN vs. The Competition Export to ExcelMetricInogenSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$179.23M$9.36B$5.31B$8.28BDividend YieldN/A1.27%5.20%4.10%P/E Ratio-2.9620.5726.7319.58Price / Sales0.5361.23387.44119.65Price / CashN/A19.6738.2534.62Price / Book0.765.086.744.47Net Income-$102.45M$284.66M$3.23B$248.22M7 Day Performance9.46%-2.46%-0.05%-1.32%1 Month Performance-3.11%-1.27%8.51%10.73%1 Year Performance-19.20%-21.11%18.25%8.40% Inogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INGNInogen4.1351 of 5 stars$6.67-1.2%$9.50+42.5%-21.9%$179.23M$339.96M-2.961,030Analyst UpgradeBBNXBeta BionicsN/A$15.10+5.2%$24.83+64.5%N/A$654.68M$69.83M0.00294Gap UpCBLLCeriBell2.7212 of 5 stars$17.83-0.8%$32.50+82.3%N/A$644.43M$71.54M0.00N/APositive NewsGap UpDCTHDelcath Systems3.0952 of 5 stars$18.10+5.8%$22.75+25.7%+105.7%$630.35M$53.85M-13.4160Positive NewsAnalyst ForecastAVNSAvanos Medical2.6573 of 5 stars$13.00-0.8%N/A-38.6%$601.17M$689.20M38.244,040Positive NewsBFLYButterfly Network2.6154 of 5 stars$2.32-1.3%$4.00+72.4%+106.5%$573.71M$85.63M-5.04460Gap UpBVSBioventus3.147 of 5 stars$6.93+2.1%$14.33+106.8%+3.3%$567.87M$567.70M-11.361,200Gap UpKIDSOrthoPediatrics4.6057 of 5 stars$22.95-0.5%$35.83+56.1%-36.2%$557.39M$212.45M-18.66200Positive NewsNPCENeuroPace1.4384 of 5 stars$17.00-2.8%$15.00-11.8%+125.1%$556.80M$79.91M-17.00170High Trading VolumeAXGNAxoGen3.2587 of 5 stars$11.76-0.6%$22.20+88.8%+76.5%$535.60M$194.52M-36.75450SMLRSemler Scientific2.5506 of 5 stars$43.27+5.8%$71.00+64.1%+92.4%$482.55M$56.29M8.81120News CoverageAnalyst DowngradeOptions VolumeGap UpHigh Trading Volume Related Companies and Tools Related Companies Beta Bionics Alternatives CeriBell Alternatives Delcath Systems Alternatives Avanos Medical Alternatives Butterfly Network Alternatives Bioventus Alternatives OrthoPediatrics Alternatives NeuroPace Alternatives AxoGen Alternatives Semler Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INGN) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INGN Stock Free INGN Stock Alerts